Article
Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25.
Microbiology spectrum - 1 Sept 2026
Patel Mira C, Nguyen Ha T, Pascua Philippe Noriel Q, Lopez-Esteva Mercedes, Champion Chloe, Mishin Vasiliy P, Di Han, Lacek Kristine, Kirby Marie K, Bateman Allen, Sullivan Maureen, Trow Susan, Laplante Jennifer, St George Kirsten, Rambo-Martin Benjamin, Merced-Morales Angiezel, Budd Alicia, Kondor Rebecca J, Davis Charles T, Gubareva Larisa V
Abstract excerpt
During the high severity season of 2024-25, CDC with public health partners sequenced and analyzed genomes of >10,000 influenza viruses for antiviral resistance markers. Available sequence-flagged and representative viruses were tested with antivirals using in vitro assays. In the US, three oseltamivir-resistant A(H3N2) viruses had treatment-emergent neuraminidase (NA) mutations, either E119V or R292K....
Read the complete abstract on PubMedTopics
- Antiviral Agents
- Humans
- Drug Resistance, Viral
- Influenza, Human
